[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Utilization and Complications of Catheter Ablation Therapy for Cardiac Arrhythmias in Congenital Heart Disease: An Analysis of the National Inpatient Sample (NIS) Database",
    "section": "",
    "text": "Reference Papers:\n\nRozen et al. 2020\nAlhassan et al. 2023\nHosseini et al. 2017\n\nStudy Objective: Describe the utilization and outcomes of catheter ablation therapy for cardiac arrhythmias in patients with congenital heart disease (CHD)\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions for patients aged 18 years or older with CHD who underwent catheter ablation with atrial fibrillation, atrial flutter, supraventricular tachycardia, or ventricular tachycardia as the primary diagnosis. Excluded patients who underwent pacemaker implantation, implantable cardioverter-defibrillator insertion, or open surgical ablation during the same hospitalization to avoid confounding effects from these procedures.\nPrimary Outcomes:\n\nAt least 1 Complication\nIn-hospital all-cause mortality\nLength of stay (days)\nInflation-adjusted total charge ($)\n\nSecondary Outcomes:\n\nPericardial complications (Hemopericardium, Pericardial Effusion, Cardiac Tamponade, Pericardiocentesis, Acute Pericarditis)\nCardiac complications (Myocardial Injury, Myocardial Arrest, Myocardial Infarction, Postprocedural Heart Failure, Requiring Open Heart Surgery, Postcardiotomy Syndrome)\nVascular complications (Hemorrhage/Hematoma, Hemo-transfusion, Accidental Puncture, Vascular Injury, Fistulas/Aneurysms, Injury Requiring Surgical Repair)\nRespiratory complications (Pneumothorax/Hemothorax, Diaphragmatic Paralysis, Postoperative Respiratory Failure)\nGastrointestinal complications (Esophageal Perforation, Esophageal Injury)\nNeurological Complications\n\nStatistical Analysis: Multiple logistic regression model was used to evaluate predictors of complication rates including:\n\nDemographics: Age, sex, race, residential income, insurance type, and admission type (elective vs. non-elective).\nMedical History: Hypertension, obesity, obstructive sleep apnea, diabetes mellitus, chronic pulmonary disease, chronic kidney disease\nAblation-Related Factors: Indication for Ablation\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Utilization and Complications of Catheter Ablation Therapy for Cardiac Arrhythmias in Congenital Heart Disease: An Analysis of the National Inpatient Sample (NIS) Database",
    "section": "",
    "text": "Reference Papers:\n\nRozen et al. 2020\nAlhassan et al. 2023\nHosseini et al. 2017\n\nStudy Objective: Describe the utilization and outcomes of catheter ablation therapy for cardiac arrhythmias in patients with congenital heart disease (CHD)\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions for patients aged 18 years or older with CHD who underwent catheter ablation with atrial fibrillation, atrial flutter, supraventricular tachycardia, or ventricular tachycardia as the primary diagnosis. Excluded patients who underwent pacemaker implantation, implantable cardioverter-defibrillator insertion, or open surgical ablation during the same hospitalization to avoid confounding effects from these procedures.\nPrimary Outcomes:\n\nAt least 1 Complication\nIn-hospital all-cause mortality\nLength of stay (days)\nInflation-adjusted total charge ($)\n\nSecondary Outcomes:\n\nPericardial complications (Hemopericardium, Pericardial Effusion, Cardiac Tamponade, Pericardiocentesis, Acute Pericarditis)\nCardiac complications (Myocardial Injury, Myocardial Arrest, Myocardial Infarction, Postprocedural Heart Failure, Requiring Open Heart Surgery, Postcardiotomy Syndrome)\nVascular complications (Hemorrhage/Hematoma, Hemo-transfusion, Accidental Puncture, Vascular Injury, Fistulas/Aneurysms, Injury Requiring Surgical Repair)\nRespiratory complications (Pneumothorax/Hemothorax, Diaphragmatic Paralysis, Postoperative Respiratory Failure)\nGastrointestinal complications (Esophageal Perforation, Esophageal Injury)\nNeurological Complications\n\nStatistical Analysis: Multiple logistic regression model was used to evaluate predictors of complication rates including:\n\nDemographics: Age, sex, race, residential income, insurance type, and admission type (elective vs. non-elective).\nMedical History: Hypertension, obesity, obstructive sleep apnea, diabetes mellitus, chronic pulmonary disease, chronic kidney disease\nAblation-Related Factors: Indication for Ablation\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Utilization and Complications of Catheter Ablation Therapy for Cardiac Arrhythmias in Congenital Heart Disease: An Analysis of the National Inpatient Sample (NIS) Database",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nN = 2,370\n\n\n\n\nAge, y, n (%)\n\n\n\n\n    18–44y\n430 (18)\n\n\n    45–59y\n620 (26)\n\n\n    60–74y\n965 (41)\n\n\n    ≥75y\n355 (15)\n\n\nSex, n (%)\n\n\n\n\n    Female\n930 (39)\n\n\n    Male\n1,440 (61)\n\n\nRace, n (%)\n\n\n\n\n    White\n1,845 (80)\n\n\n    Black\n190 (8.2)\n\n\n    Hispanic\n190 (8.2)\n\n\n    Other\n95 (4.1)\n\n\nResidential income, n (%)\n\n\n\n\n    $1 - $51,999\n500 (22)\n\n\n    $52,000 - $65,999\n635 (27)\n\n\n    $66,000 - $87,999\n555 (24)\n\n\n    $88,000 or more\n635 (27)\n\n\nExpected primary payer, n (%)\n\n\n\n\n    Private\n915 (39)\n\n\n    Medicaid\n250 (11)\n\n\n    Medicare\n1,130 (48)\n\n\n    Other\n70 (3.0)\n\n\nHospital region, n (%)\n\n\n\n\n    Midwest\n545 (23)\n\n\n    Northeast\n615 (26)\n\n\n    South\n830 (35)\n\n\n    West\n380 (16)\n\n\nHospital bedsize, n (%)\n\n\n\n\n    Large\n1,530 (65)\n\n\n    Medium\n595 (25)\n\n\n    Small\n245 (10)\n\n\nHospital location and teaching status, n (%)\n\n\n\n\n    Rural\n75 (3.2)\n\n\n    Urban, non-teaching\n160 (6.8)\n\n\n    Urban, teaching\n2,135 (90)\n\n\nAdmission type, n (%)\n\n\n\n\n    Elective\n875 (37)\n\n\n    Non-elective\n1,495 (63)\n\n\nCharlson comorbidity index, Mean (SD)\n1.92 (1.83)\n\n\nIndication for ablation, n (%)\n\n\n\n\n    Atrial Fibrillation\n1,045 (44)\n\n\n    Atrial Flutter\n805 (34)\n\n\n    Supraventricular Tachycardia\n305 (13)\n\n\n    Ventricular Tachycardia\n215 (9.1)\n\n\nHypertension, n (%)\n1,215 (51)\n\n\nObesity, n (%)\n630 (27)\n\n\nObstructive sleep apnea, n (%)\n545 (23)\n\n\nDiabetes Mellitus, n (%)\n620 (26)\n\n\nChronic pulmonary disease, n (%)\n470 (20)\n\n\nChronic kidney disease, n (%)\n345 (15)"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Utilization and Complications of Catheter Ablation Therapy for Cardiac Arrhythmias in Congenital Heart Disease: An Analysis of the National Inpatient Sample (NIS) Database",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nN = 2,370\n\n\n\n\nDeath, n (%)\n15 (0.6)\n\n\nLength of stay (days), Median (IQR)\n3.0 (2.0 – 6.0)\n\n\nAdjusted total charges, Median (IQR)\n138,056 (99,076 – 202,284)\n\n\nPericardial Complications, n (%)\n175 (7.4)\n\n\nCardiac Complications, n (%)\n50 (2.1)\n\n\nVascular Complications, n (%)\n70 (3.0)\n\n\nRespiratory Complications, n (%)\n15 (0.6)\n\n\nGastrointestinal Complications, n (%)\n20 (0.8)\n\n\nNeurological Complications, n (%)\n15 (0.6)\n\n\nAt Least 1 Complication, n (%)\n\n\n\n\n    At Least 1 Complication\n275 (12)\n\n\n    No Complications\n2,095 (88)"
  },
  {
    "objectID": "quarto/index.html#baseline-table-of-patients-with-and-without-any-complications",
    "href": "quarto/index.html#baseline-table-of-patients-with-and-without-any-complications",
    "title": "Utilization and Complications of Catheter Ablation Therapy for Cardiac Arrhythmias in Congenital Heart Disease: An Analysis of the National Inpatient Sample (NIS) Database",
    "section": "Baseline Table of Patients With and Without Any Complications:",
    "text": "Baseline Table of Patients With and Without Any Complications:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nAt Least 1 Complication N = 275\nNo Complications N = 2,095\np-value1\n\n\n\n\nAge, y, n (%)\n\n\n\n\n0.17\n\n\n    18–44y\n30 (11)\n400 (19)\n\n\n\n\n    45–59y\n65 (24)\n555 (26)\n\n\n\n\n    60–74y\n115 (42)\n850 (41)\n\n\n\n\n    ≥75y\n65 (24)\n290 (14)\n\n\n\n\nSex, n (%)\n\n\n\n\n0.027\n\n\n    Female\n145 (53)\n785 (37)\n\n\n\n\n    Male\n130 (47)\n1,310 (63)\n\n\n\n\nRace, n (%)\n\n\n\n\n0.68\n\n\n    White\n230 (84)\n1,615 (79)\n\n\n\n\n    Black\n15 (5.5)\n175 (8.6)\n\n\n\n\n    Hispanic\n15 (5.5)\n175 (8.6)\n\n\n\n\n    Other\n15 (5.5)\n80 (3.9)\n\n\n\n\nResidential income, n (%)\n\n\n\n\n0.30\n\n\n    $1 - $51,999\n45 (17)\n455 (22)\n\n\n\n\n    $52,000 - $65,999\n85 (31)\n550 (27)\n\n\n\n\n    $66,000 - $87,999\n45 (17)\n510 (25)\n\n\n\n\n    $88,000 or more\n95 (35)\n540 (26)\n\n\n\n\nExpected primary payer, n (%)\n\n\n\n\n0.74\n\n\n    Private\n95 (35)\n820 (39)\n\n\n\n\n    Medicaid\n25 (9.1)\n225 (11)\n\n\n\n\n    Medicare\n150 (55)\n980 (47)\n\n\n\n\n    Other\n5 (1.8)\n65 (3.1)\n\n\n\n\nHospital region, n (%)\n\n\n\n\n0.83\n\n\n    Midwest\n70 (25)\n475 (23)\n\n\n\n\n    Northeast\n65 (24)\n550 (26)\n\n\n\n\n    South\n105 (38)\n725 (35)\n\n\n\n\n    West\n35 (13)\n345 (16)\n\n\n\n\nHospital bedsize, n (%)\n\n\n\n\n0.22\n\n\n    Large\n195 (71)\n1,335 (64)\n\n\n\n\n    Medium\n70 (25)\n525 (25)\n\n\n\n\n    Small\n10 (3.6)\n235 (11)\n\n\n\n\nHospital location and teaching status, n (%)\n\n\n\n\n0.12\n\n\n    Rural\n10 (3.6)\n65 (3.1)\n\n\n\n\n    Urban, non-teaching\n0 (0)\n160 (7.6)\n\n\n\n\n    Urban, teaching\n265 (96)\n1,870 (89)\n\n\n\n\nAdmission type, n (%)\n\n\n\n\n0.17\n\n\n    Elective\n125 (45)\n750 (36)\n\n\n\n\n    Non-elective\n150 (55)\n1,345 (64)\n\n\n\n\nCharlson comorbidity index, Mean (SD)\n2.16 (2.37)\n1.89 (1.75)\n0.92\n\n\nIndication for ablation, n (%)\n\n\n\n\n0.010\n\n\n    Atrial Fibrillation\n170 (62)\n875 (42)\n\n\n\n\n    Atrial Flutter\n40 (15)\n765 (37)\n\n\n\n\n    Supraventricular Tachycardia\n40 (15)\n265 (13)\n\n\n\n\n    Ventricular Tachycardia\n25 (9.1)\n190 (9.1)\n\n\n\n\nHypertension, n (%)\n155 (56)\n1,060 (51)\n0.41\n\n\nObesity, n (%)\n75 (27)\n555 (26)\n0.91\n\n\nObstructive sleep apnea, n (%)\n60 (22)\n485 (23)\n0.82\n\n\nDiabetes Mellitus, n (%)\n65 (24)\n555 (26)\n0.65\n\n\nChronic pulmonary disease, n (%)\n70 (25)\n400 (19)\n0.24\n\n\nChronic kidney disease, n (%)\n35 (13)\n310 (15)\n0.69\n\n\n\n1 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Utilization and Complications of Catheter Ablation Therapy for Cardiac Arrhythmias in Congenital Heart Disease: An Analysis of the National Inpatient Sample (NIS) Database",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAt least 1 Complication:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR (95% CI)1\np-value\n\n\n\n\nAge, y\n\n\n\n\n\n\n    18–44y\n—\n\n\n\n\n    45–59y\n0.54 (0.18 to 1.63)\n0.27\n\n\n    60–74y\n0.43 (0.13 to 1.40)\n0.16\n\n\n    ≥75y\n0.22 (0.05 to 0.94)\n0.042\n\n\nSex\n\n\n\n\n\n\n    Female\n—\n\n\n\n\n    Male\n1.61 (0.88 to 2.95)\n0.12\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Black\n1.14 (0.29 to 4.53)\n0.85\n\n\n    Hispanic\n0.99 (0.29 to 3.32)\n0.98\n\n\n    Other\n0.73 (0.18 to 3.07)\n0.67\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n0.66 (0.28 to 1.55)\n0.34\n\n\n    $66,000 - $87,999\n1.12 (0.40 to 3.17)\n0.83\n\n\n    $88,000 or more\n0.62 (0.26 to 1.49)\n0.29\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n0.79 (0.25 to 2.48)\n0.68\n\n\n    Medicare\n1.26 (0.52 to 3.03)\n0.60\n\n\n    Other\n1.38 (0.17 to 11.4)\n0.76\n\n\nAdmission type\n\n\n\n\n\n\n    Elective\n—\n\n\n\n\n    Non-elective\n1.18 (0.63 to 2.21)\n0.60\n\n\nAblation type\n\n\n\n\n\n\n    Atrial Fibrillation\n—\n\n\n\n\n    Atrial Flutter\n3.32 (1.44 to 7.62)\n0.005\n\n\n    Supraventricular Tachycardia\n1.31 (0.49 to 3.46)\n0.59\n\n\n    Ventricular Tachycardia\n1.00 (0.35 to 2.90)\n&gt;0.99\n\n\nHypertension\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.99 (0.47 to 2.11)\n0.99\n\n\nObesity\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.98 (0.45 to 2.10)\n0.95\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.09 (0.49 to 2.42)\n0.84\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.57 (0.77 to 3.19)\n0.22\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.73 (0.38 to 1.41)\n0.35\n\n\nChronic kidney disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.23 (0.43 to 3.51)\n0.70\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval"
  }
]